Ugo Cavallaro
11PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Apr 28, 2025
Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth.Hilary A Kenny, Carman Ka Man Ip, Lucy Kelliher
|Feb 03, 2025
Early tolerance and late persistence as alternative drug responses in cancer.Simona Punzi, Davide Cittaro, Guido Gatti
|May 28, 2024
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness.Chiara Battistini, Hilary A Kenny, Melissa Zambuto
|Mar 28, 2023
Matrix Gla Protein drives stemness and tumor initiation in ovarian cancer.V Nieddu, V Melocchi, C Battistini
|Jan 21, 2023
Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments.Chiara Battistini, Ugo Cavallaro
|Jul 09, 2022
Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer.Kristin L M Boylan, Ashley Petersen, Timothy K Starr
Pageof 2
Frequent Collaborators
5 joint publications
Chiara Battistini
2 joint publications
Valentina Nieddu
2 joint publications
Valentina Melocchi
2 joint publications
Ernst Lengyel
2 joint publications
Giovanni Bertalot
2 joint publications
Fabrizio Bianchi
2 joint publications
Giuseppe Testa
2 joint publications
Raffaella Giavazzi
1 joint publications
M Lupia
1 joint publications
J V Olsen
